Search Results - "Mahendra, Premini"
-
1
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
Published in The Journal of experimental medicine (01-08-2005)“…Stem cell transplantation is used widely in the management of a range of diseases of the hemopoietic system. Patients are immunosuppressed profoundly in the…”
Get full text
Journal Article -
2
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation
Published in Blood (01-12-2007)“…Acute graft-versus-host disease (aGVHD) remains a serious complication following allogeneic stem-cell transplantation (SCT), and is mediated by infiltration of…”
Get full text
Journal Article -
3
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
Published in Journal of clinical oncology (20-12-2005)“…The toxicity of allogeneic stem-cell transplantation can be substantially reduced using a reduced-intensity conditioning (RIC) regimen. This has increased the…”
Get full text
Journal Article -
4
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
Published in Blood (15-06-2002)“…Nonmyeloablative conditioning is increasingly used for transplantation in a wide range of diseases, but little is known about its impact on the incidence of…”
Get full text
Journal Article -
5
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
Published in Blood (01-02-2002)“…A nonmyeloablative conditioning regimen was investigated in 47 patients with hematological malignancy receiving allogeneic progenitor cells from matched,…”
Get full text
Journal Article -
6
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
Published in Blood (01-10-2000)“…A novel nonmyeloablative conditioning regimen was investigated in 44 patients with hematologic malignancies. The median patient age was 41 years. Many of the…”
Get full text
Journal Article -
7
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition
Published in Proceedings of the National Academy of Sciences - PNAS (10-03-2009)“…T cell recognition of minor histocompatibility antigens (mHags) underlies allogeneic immune responses that mediate graft-versus-host disease and the…”
Get full text
Journal Article -
8
CD8+ T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect
Published in Haematologica (Roma) (01-09-2010)“…Allogeneic stem cell transplantation is associated with a powerful 'graft-versus-leukemia' effect that is generally considered to result from an alloreactive…”
Get full text
Journal Article -
9
An ABVD-Based Approach Confers Superior Outcomes for Adolescent and Young Adult Patients Compared to Other Adults with Advanced Classical Hodgkin Lymphoma
Published in Blood (08-12-2017)“…Combination chemotherapy with ABVD is widely used as first line therapy for adult classical Hodgkin lymphoma (cHL). However, for patients in the Adolescent and…”
Get full text
Journal Article -
10
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
Published in The Lancet (British edition) (04-06-2005)“…In patients with multiply relapsed Hodgkin's lymphoma allogeneic stem-cell transplantation has been limited by prohibitive non-relapse-related mortality rates…”
Get full text
Journal Article -
11
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation
Published in Blood (01-02-2006)“…Reactivation of cytomegalovirus (CMV) is a common complication following allogeneic stem cell transplantation. Genetic determinants in the host and donor that…”
Get full text
Journal Article -
12
Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long‐term outcomes
Published in British journal of haematology (01-10-2007)“…Summary The introduction of reduced‐intensity conditioning (RIC) has enabled the role of allogeneic transplantation to be re‐evaluated in Hodgkin lymphoma…”
Get full text
Journal Article -
13
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia
Published in Blood (15-02-2004)“…Killer immunoglobulin–like receptors (KIRs) regulate cell activity of natural killer (NK) cells and some T cells. The predominant ligand for inhibitory KIRs is…”
Get full text
Journal Article -
14
The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study
Published in British journal of haematology (01-08-2006)“…Summary The outcome of high‐dose chemotherapy (HDT) was evaluated retrospectively in 27 patients with myeloma and four patients with AL amyloidosis with severe…”
Get full text
Journal Article -
15
Dose‐intensified treatment of Burkitt lymphoma and B‐cell lymphoma unclassifiable, (with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols
Published in American journal of hematology (01-04-2010)“…The chemotherapy dose‐intensity in two adapted German BFM paediatric protocols (BFM 90 and NHL 86) was compared in contemporaneously treated adults <50 years…”
Get full text
Journal Article -
16
Reduced Intensity Allogeneic Tranplants Are Well Tolerated In Patients Over the Age of 60: Identification of Factors Predicting Overall Survival
Published in Blood (19-11-2010)“…Abstract 2361 Reduced intensity allogeneic transplants represent a potentially curative therapy in older patients with haematological malignancies. However the…”
Get full text
Journal Article -
17
Expansion of CD38+ Activated B Cells in Circulation as a Manifestation of Early Onset EBV Associated Post-Transplant Lymphoproliferative Disease
Published in Blood (16-11-2007)“…Epstein-Barr virus (EBV)-associated lymphoproliferative disease (LPD) is an uncommon but potentially fatal complication of allogeneic haematopoietic stem cell…”
Get full text
Journal Article -
18
Intensifying Methotrexate (MTX) Dosage Reduces Treatment Failure in Adults with Burkitt or Burkitt-Like Leukaemia/Lymphoma (BL) Treated with an Adapted BFM Protocol
Published in Blood (16-11-2006)“…The use of short-duration intensive combination chemotherapy protocols has improved survival in adults with Burkitt/Burkitt-like leukaemia and lymphoma (BL)…”
Get full text
Journal Article -
19
Origin and subset distribution of peripheral blood dendritic cells in patients with chronic Graft-Versus-Host disease
Published in Transplantation (27-01-2003)“…After allogeneic hematopoietic stem cell transplantation, donor T cells interact with an antigen-presenting cell environment that is distorted in number, level…”
Get full text
Journal Article -
20
CD8+ T Cells Specific for Cancer-Testis Antigens Are Found in Many Patients with Multiple Myeloma and Correlate with Disease Burden
Published in Blood (16-11-2004)“…Proteins from the family known as ‘cancer-testis antigens' (CTAg) are expressed in some cases of multiple myeloma and subsets of acute myeloid leukaemia. CTAg…”
Get full text
Journal Article